0 XP 0   0   0  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Biofrontera Inc - Trending symbols

Latest News of Biofrontera Inc

DateTitleRead
2025-11-06
22:01
Biofrontera Inc. to Report Third Quarter 2025 Financial Results on November 12, 2025 and Host a Conference Call on November 13, 2025Read
2025-10-23
14:45
Biofrontera Inc. Closes Purchase of All Ameluz® and RhodoLED® US Assets from Biofrontera AGRead



Trends

 2024-06-302024-09-302024-12-312025-03-312025-06-30
Total Stockholder Equity 10,911-5,3815,530-1,0974,433-3,964469-5,137-4,668
Net Invested Capital 11,207-5,6775,5303,0018,531-3,8454,686-5,016-330
Net Working Capital 8,203-2,3045,8992,7808,679-4,3064,373-5,245-872
Depreciation and Amortization 2951230723093312-1,240-928
Net Interest Income -142-162-304-1,103-1,407811-5966048
Net Income from Continuing Operations -2,785-4,693-7,478-2,359-9,8373,495-6,3429,8683,526
Net Debt -15,8623,566-12,29610,038-2,2581,650-6084,6644,056
Income before Tax -2,784-4,689-7,473-2,350-9,8233,482-6,3419,8613,520
Net Income -2,785-4,693-7,478-2,359-9,8373,495-6,3429,8683,526
Tax Provision 145914-131-7-6
Income Tax Expense 145914-131-7-6
Interest Expense 92-573503586121-263-142
Net Income Applicable to Common Shares -3,534-127-3,661-12,351-16,0121,507-14,50520,0665,561

Comments

How you think about this?

Leave a comment

Stay informed about Biofrontera Inc.

Receive notifications about Biofrontera Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.